Equities research analysts at StockNews.com started coverage on shares of Cutera (NASDAQ:CUTR – Get Free Report) in a report issued on Sunday. The firm set a “sell” rating on the medical device company’s stock.
Cutera Stock Performance
Shares of CUTR opened at $0.62 on Friday. The stock has a market capitalization of $12.51 million, a PE ratio of -0.09 and a beta of 1.31. The company’s fifty day moving average is $0.41 and its 200 day moving average is $0.79. Cutera has a fifty-two week low of $0.28 and a fifty-two week high of $4.97.
Institutional Inflows and Outflows
A number of institutional investors have recently made changes to their positions in CUTR. Squarepoint Ops LLC increased its stake in Cutera by 164.5% during the second quarter. Squarepoint Ops LLC now owns 113,964 shares of the medical device company’s stock worth $172,000 after acquiring an additional 70,870 shares during the last quarter. Bank of Montreal Can boosted its holdings in shares of Cutera by 14.2% in the 2nd quarter. Bank of Montreal Can now owns 282,704 shares of the medical device company’s stock worth $455,000 after purchasing an additional 35,248 shares during the period. Finally, Ground Swell Capital LLC bought a new position in shares of Cutera during the 2nd quarter valued at approximately $37,000. Institutional investors own 90.70% of the company’s stock.
About Cutera
Cutera, Inc provides aesthetic and dermatology solutions for medical practitioners worldwide. It develops, manufactures, and markets energy-based product platforms for medical practitioners; and distributes third-party manufactured skincare products. The company provides AviClear for the treatment of mild, moderate, and severe inflammatory acne vulgaris; Secret PRO, a device that utilizes fractional CO2 for skin resurfacing and radio frequency (RF) microneedling for skin revitalization; truFlex, a bio-electrical muscle stimulation device designs to strengthen, firm and tone the abdomen, buttocks, and thighs; and excel V/V+, a vascular and benign pigmented lesion treatment platform.
Read More
- Five stocks we like better than Cutera
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- How to trade using analyst ratings
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Stock Average Calculator
- How Cigna Remains at the Top of the Health Insurance Food Chain
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.
